Allergan settles for $200M with New York over opioids

Allergan settles for $200M with New York over opioids

FILE - This photo shows an arrangement of Oxycodone pills in New York on Aug. 29, 2018. The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state's public nuisance law. The court ruled in a 5-1 decision Tuesday, Nov. 9, 2021, that the district court in 2019 was wrong to find that New Jersey-based J&J and its Belgium-based subsidiary Janssen Pharmaceuticals violated the state's public nuisance statute. (AP Photo/Mark Lennihan, File)

NEW YORK (AP) — Pharmaceutical company Allergan Finance LLC will pay $200 million to New York state and two of its counties as part of an agreement that removes it from an ongoing state lawsuit over the opioid crisis. In the agreement, Allergan did not admit to any liability. In a statement, the company said it was “pleased” to have reached the settlement. The agreement with Allergan means only Teva Pharmaceuticals is remaining as a defendant in a trial that has been taking place in Suffolk County in recent months; closing arguments were scheduled to start on Wednesday. Other settlements had been reached earlier in the trial process and before it began.

Photo: FILE – This photo shows an arrangement of Oxycodone pills in New York on Aug. 29, 2018. (AP Photo/Mark Lennihan, File)